The Utility of a Controlled Human Infection Model for Developing Leishmaniasis Vaccines
Crossref DOI link: https://doi.org/10.1007/978-3-031-24355-4_12
Published Online: 2023-03-28
Published Print: 2023
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kaye, Paul M.
Parkash, Vivak
Layton, Alison M.
Lacey, Charles J. N.
Text and Data Mining valid from 2023-01-01
Version of Record valid from 2023-03-28
Chapter History
First Online: 28 March 2023